I think it’s very good news. I’m impressed by the support from an expert from Tufts. This type of a vaccine is far safer than others currently further in development so a secondary focus on children and pregnant women is a great unchartered avenue. Joe did a great job on a complex deal involving lawyers etc from overseas and hopefully all aspects of this just keep moving forward while other deals are finalized in Canada and China.